First Quarter M&A Activity Rose On The Strength Of Three Deals

 
• By Joseph Haas

The biopharma sector made acquisitions with total potential value of $33.6bn during Q1, up substantially from the $9.5bn of Q4 2024, according to data from Evaluate.

Merger
Bolt-on acquisitions remained the order of the day in Q1, despite one $14bn+ deal • Source: Shutterstock

More from Deals

More from Strategy